​
​

Barinthus Biotherapeutics (BRNS) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

Barinthus Biotherapeutics Revenue Highlights

Latest Revenue (Y)

$805.11K

0

Main Segment (Y)

License

Barinthus Biotherapeutics Revenue by Period

Barinthus Biotherapeutics Revenue by Year

DateRevenueChange
2023-12-31$805.11K-98.20%
2022-12-31$44.70M16580.22%
2021-12-31$268.00K-94.44%
2020-12-31$4.82M-29.86%
2019-12-31$6.87M-

Barinthus Biotherapeutics generated $805.11K in revenue during NA 2023, up -98.20% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Barinthus Biotherapeutics Revenue by Quarter

DateRevenueChange
2024-06-30-100.00%
2024-03-31--100.00%
2023-12-31$5.37M100.00%
2023-09-30--100.00%
2023-06-30$334.00K-28.63%
2023-03-31$468.00K-92.75%
2022-12-31$6.46M4.74%
2022-09-30$6.17M-63.87%
2022-06-30$17.06M13.62%
2022-03-31$15.02M-1501900.00%
2021-12-31$-1.00K-105.26%
2021-09-30$19.00K-45.71%
2021-06-30$35.00K-83.72%
2021-03-31$215.00K-39.14%
2020-12-31$353.26K-89.13%
2020-09-30$3.25M536.20%
2020-06-30$511.00K-27.52%
2020-03-31$705.00K-

Barinthus Biotherapeutics generated - in revenue during Q2 2024, up 100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Barinthus Biotherapeutics Revenue Breakdown

Barinthus Biotherapeutics Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 23
License$802.00K
Research Grants And Contracts-

Barinthus Biotherapeutics's latest annual revenue breakdown by segment (product or service), as of Dec 23: License (100.00%).

Quarterly Revenue by Product

Product/ServiceSep 24
License$14.97M

Barinthus Biotherapeutics's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: License (100.00%).

BRNS Revenue FAQ

What is Barinthus Biotherapeutics’s yearly revenue?

Barinthus Biotherapeutics's yearly revenue for 2023 was $805.11K, representing a decrease of -98.20% compared to 2022. The company's yearly revenue for 2022 was $44.7M, representing an increase of 16580.22% compared to 2021. BRNS's yearly revenue for 2021 was $268K, representing a decrease of -94.44% compared to 2020.

What is Barinthus Biotherapeutics’s quarterly revenue?

Barinthus Biotherapeutics's quarterly revenue for Q2 2024 was $0, a 100.00% increase from the previous quarter (Q1 2024), and a -100.00% decrease year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $0, a -100.00% decrease from the previous quarter (Q4 2023), and a -100.00% decrease year-over-year (Q1 2023). BRNS's quarterly revenue for Q4 2023 was $5.37M, a 100.00% increase from the previous quarter (Q3 2023), and a -16.85% decrease year-over-year (Q4 2022).

What is Barinthus Biotherapeutics’s revenue growth rate?

Barinthus Biotherapeutics's revenue growth rate for the last 3 years (2021-2023) was 200.41%, and for the last 5 years (2019-2023) was -88.29%.

What are Barinthus Biotherapeutics’s revenue streams?

Barinthus Biotherapeutics's revenue streams in c 23 are License

What is Barinthus Biotherapeutics’s main source of revenue?

For the fiscal year ending Dec 23, the largest source of revenue of Barinthus Biotherapeutics was License. This segment made a revenue of $802K, representing 100.00% of the company's total revenue.